Inozyme Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 5.16 M | $14.29 M | -9.05% | 8.15% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2025 | 4.49 M | $12.45 M | 0.00% | 7.10% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 4.28 M | $11.86 M | 0.00% | 6.76% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 3.97 M | $11.00 M | 40.75% | 6.28% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 3.86 M | $10.70 M | 1.55% | 6.10% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.81 M | $10.56 M | 9.20% | 6.03% |
| VANGUARD GROUP INC | 02/11/2025 | 2.63 M | $7.29 M | 0.34% | 4.16% |
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 2.44 M | $6.75 M | 0.00% | 3.85% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 2.22 M | $6.15 M | -46.30% | 3.51% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.88 M | $5.21 M | 7.90% | 2.97% |
| FMR LLC | 02/13/2025 | 1.82 M | $5.05 M | -26.39% | 2.88% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 1.56 M | $4.33 M | 0.00% | 2.47% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.37 M | $3.81 M | 0.42% | 2.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 1.19 M | $3.30 M | 0.00% | 1.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.18 M | $3.27 M | 0.72% | 1.86% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 1.08 M | $2.99 M | -3.57% | 1.71% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.00 M | $2.78 M | 0.00% | 1.59% |
| KNOTT DAVID M JR | 02/12/2025 | 695,000 | $1.93 M | 23.11% | 1.10% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 504,670 | $1.40 M | 13.12% | 0.80% |
| SANOFI | 02/14/2025 | 443,255 | $1.23 M | 100.00% | 0.70% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 421,399 | $1.17 M | 155.70% | 0.67% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 252,722 | $700,040 | -43.50% | 0.40% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 250,229 | $693,134 | 23.43% | 0.40% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 237,620 | $658,207 | 100.00% | 0.38% |
| OVERBROOK MANAGEMENT CORP | 01/16/2025 | 219,326 | $607,533 | 0.00% | 0.35% |
| PALE FIRE CAPITAL SE | 02/13/2025 | 218,537 | $605,347 | 15.91% | 0.35% |
| UBS OCONNOR LLC | 02/14/2025 | 201,232 | $557,413 | -11.05% | 0.32% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 200,336 | $554,930 | -23.16% | 0.32% |
| ABRDN PLC | 01/24/2025 | 170,522 | $472,346 | 100.00% | 0.27% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 155,695 | $431,274 | 0.00% | 0.25% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 143,158 | $396,548 | 0.00% | 0.23% |
| JPMORGAN CHASE & CO | 02/12/2025 | 128,872 | $356,975 | 345.49% | 0.20% |
| BARCLAYS PLC | 02/13/2025 | 91,634 | $254,000 | 19.42% | 0.14% |
| JUMP FINANCIAL, LLC | 02/13/2025 | 89,291 | $247,336 | 100.00% | 0.14% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 83,919 | $232,456 | 100.00% | 0.13% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 79,349 | $219,797 | 11.62% | 0.13% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 78,700 | $217,999 | 223.87% | 0.12% |
| RHUMBLINE ADVISERS | 01/30/2025 | 77,251 | $213,978 | 0.57% | 0.12% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 76,299 | $211,348 | 100.00% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 76,200 | $211,074 | -2.81% | 0.12% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 74,165 | $205,437 | 100.00% | 0.12% |
| 02/12/2025 | 63,799 | $176,723 | 100.00% | 0.10% | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 62,886 | $174,194 | 100.00% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 61,050 | $169,109 | 100.00% | 0.10% |
| SHAY CAPITAL LLC | 02/14/2025 | 53,588 | $148,439 | 100.00% | 0.08% |
| RESOURCES INVESTMENT ADVISORS, LLC. | 02/13/2025 | 51,000 | $141,270 | 155.00% | 0.08% |
| CITIGROUP INC | 02/12/2025 | 40,403 | $111,917 | 7.31% | 0.06% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 40,215 | $111,396 | 29.06% | 0.06% |
| ALGERT GLOBAL LLC | 02/14/2025 | 39,115 | $108,000 | 100.00% | 0.06% |
| UBS GROUP AG | 02/14/2025 | 36,175 | $100,205 | 40.41% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inozyme Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 119 institutional investors and hedge funds held shares of Inozyme Pharma, Inc.. The most heavily invested institutionals were:
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.16 M
Pivotal bioVenture Partners Investment Advisor LLC: 4.49 M
Sofinnova Investments, Inc.: 4.28 M
Affinity Asset Advisors, LLC: 3.97 M
Rock Springs Capital Management LP: 3.86 M
BlackRock Funding, Inc. /DE: 3.81 M
82.80% of Inozyme Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 55.47 M shares in the last 24 months. This purchase volume represents approximately $160.30 M in transactions.